| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Biomarin Pharmaceutical Inc(BMRN) | 367,765 | $38.1M | 34.88% |
| 2 | Dexcom Inc(DXCM) | 321,380 | $36.4M | 33.35% |
| 3 | Cytokinetics Inc(CYTK) | 164,440 | $7.5M | 6.91% |
| 4 | Acrivon Therapeutics Inc(ACRV) | 284,201 | $3.3M | 3.00% |
| 5 | Hyperfine Inc(HYPR) | 3,880,900 | $3.3M | 2.99% |
| 6 | Alkermes PLC(ALKS) | 110,000 | $2.9M | 2.63% |
| 7 | Conmed Corp(CNMD) | 27,500 | $2.4M | 2.23% |
| 8 | Neurocrine Biosciences Inc(NBIX) | 20,000 | $2.4M | 2.19% |
| 9 | Syndax Pharmaceuticals Inc(SNDX) | 70,000 | $1.8M | 1.63% |
| 10 | Chinook Therapeutics Inc(290A) | 60,000 | $1.6M | 1.44% |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 99.95% | 95.05% | -4.9% |
| Unclassified | 0.05% | 4.95% | +4.9% |
Quarter-over-quarter weight changes by market cap
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Large Cap | 69.57% | 72.84% | +3.27% |
| Mid Cap | 10.21% | 11.17% | +0.96% |
| Micro Cap | 0% | 5.99% | +5.99% |
| Small Cap | 0.01% | 5.05% | +5.04% |
| Unclassified | 0.05% | 4.95% | +4.9% |
| Mega Cap | 20.16% | 0% | -20.16% |
Quarter-over-quarter position changes